Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids
Key facts
- Who runs it
- Friends Research Institute, Inc.
- Where
- The Bronx, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 94 people enrolled
- Started
- 28 Mar 2025
- Ended
- 31 Aug 2025
- Type of study
- Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- PRC supported text + AI driven SDH-enhanced text
- AI driven SDH-enhanced text only
- Treatment as Usual (TAU)
- Record updated
- 8 September 2026
- Why it stopped
- Loss of sponsor funding
Who can take part
- Age
- 18 years to 99 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- ≥18 years of age
- fluent in English and/or Spanish
- self-reported non-prescription opioid use <30 days prior to consent
- provision of informed consent
- planned stay in NYC ≥12 month
- self-identified Black and/or Latinx race/ethnicity
- positive urine toxicology for opioids per EMR records
- diagnosis of OUD per the Diagnostic and Statistical Manual of Mental Disorders-5
- self-reported interest in initiating buprenorphine in primary care
- must have a mobile phone data plan
Who cannot take part
- self-reported receipt of medications for OUD in past 30 days
- inability to comprehend text content written at a 3rd grade reading level
- physical or visual disability preventing mobile phone use
Where in United States
- NYC Health + HospitalsThe Bronx, United States
About the trial
What the trial wants to find out
Black and Latinx people who use opioids are disproportionately impacted by opioid overdose deaths. The proposed study assesses the efficacy of an open source, multimodal artificial intelligence-driven texting tool combined with peer recovery coach-supported text contact that delivers social services, stigma reduction, health habitus, and patient navigation content addressing social determinants of health to enhance receipt of buprenorphine in primary care among emergency department-enrolled Black / Latinx people who use opioids.
The 3 groups in the trial
- Intervention Arm-1: PRC supported text+ AI driven SDH-enhanced textTreatment being tested
Participants in this arm will receive a combination of Peer Recovery Coaches (PRCs) supported text-based care/services coordination alongside AI-driven SDH-enhanced text messages to enhance the receipt of buprenorphine in Black/ Latin people who use opioids.
Treatment: PRC supported text + AI driven SDH-enhanced text
- Intervention Arm-2: AI driven SDH-enhanced text onlyTreatment being tested
Participants in this arm will receive AI-driven SDH-enhanced text messages to enhance the receipt of buprenorphine in Black/ Latin people who use opioids. Unlike Arm-1, this intervention does not include the additional support and coordination provided by Peer Recovery Coaches.
Treatment: AI driven SDH-enhanced text only
- Control Arm 3- Treatment as UsualPlacebo, for comparison
Control Arm-3 will receive treatment as usual (i.e., verbal instructions, NYC Dept of Health pamphlets detailing access to OUD and social services, health system smartphone application EMR patient portal).
Treatment: Treatment as Usual (TAU)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Leveraging Social Determinants Via Artificial Intelligence and Peer Coaching to Address Racial Disparities in Primary Care Among People Who Use Opioids
- Record updated
- 8 September 2026